{"id":36553,"date":"2016-10-11T11:47:00","date_gmt":"2016-10-11T09:47:00","guid":{"rendered":"https:\/\/www.syncrosome.com\/?p=987"},"modified":"2026-04-17T17:51:10","modified_gmt":"2026-04-17T15:51:10","slug":"parkinson-in-vivo-preclinical-disease-model","status":"publish","type":"post","link":"https:\/\/www.etap-lab.com\/en\/science-and-innovation\/parkinson-in-vivo-preclinical-disease-model\/","title":{"rendered":"BACK from the 2nd Annual Neuroscience R&#038;D Technologies Conference"},"content":{"rendered":"\n<p>Syncrosome, participated last week to the Neuroscience R&amp;D Technologies Conference in London, to present key Parkinson&#8217;s data.<\/p>\n\n\n\n<p>It was 2 very interesting days spent to discuss about the new advances in Imaging of Neurodegeneration, Alzheimer and <strong>Parkinson\u2019s Disease<\/strong> and Drug Discovery, New trends in Preclinical animal models and Neuroimaging\u2026.<\/p>\n\n\n\n<p>Our Scientific representative, Sandra Robelet, launched a talk on the new preclinical strategy combining <strong>in vitro<\/strong> and <strong>in vivo<\/strong> models to assess the drug efficacy of your compounds in Neurodegenerative disease and interacted with Pharma and Biotech\u2019s companies from all around the world. This talk has been very appreciated from the audience due to the continuation between in vitro and in vivo strategies in Parkinson disease.<\/p>\n\n\n\n<p>An other interesting point discussed, was the <strong>CNS-PK tools<\/strong> (CSF sampling and Microdialysis with the monitoring of Neurotransmitters) that could complete the response of in vitro and in vivo disease models with a biochemical approaches of the disease.<\/p>\n\n\n\n<p>Contact us if you want to read the presentation or discuss with us directly!<\/p>\n\n\n\n<figure class=\"wp-block-image alignleft size-medium wp-image-989\"><img decoding=\"async\" src=\"https:\/\/www.etap-lab.com\/wp-content\/uploads\/2020\/12\/IMG_6076-300x225.jpg\" alt=\"Neurosciences Conference\" class=\"wp-image-989\"\/><figcaption class=\"wp-element-caption\">Neurosciences Conference<\/figcaption><\/figure>\n\n\n\n<figure class=\"wp-block-image alignright size-medium wp-image-990\"><img decoding=\"async\" src=\"https:\/\/www.etap-lab.com\/wp-content\/uploads\/2020\/12\/IMG_6080-300x225.jpg\" alt=\"In vivo and In vitro Preclinical strategy for Parkinson\" class=\"wp-image-990\"\/><figcaption class=\"wp-element-caption\">In vivo and In vitro Preclinical strategy for Parkinson<\/figcaption><\/figure>\n\n\n\n<p>&nbsp;<\/p>\n\n\n\n<p>&nbsp;<\/p>\n\n\n\n<p>&nbsp;<\/p>\n\n\n\n<p>&nbsp;<\/p>\n\n\n\n<p>&nbsp;<\/p>\n\n\n\n<p>&nbsp;<\/p>\n\n\n\n<p>&nbsp;<\/p>\n\n\n\n<p>A few words about Syncrosome:<\/p>\n\n\n\n<p>Syncrosome is an Efficacy Characterization CRO and we offer relevant disease models, cutting-edge techniques and a comprehensive background of physiopathology to assist drug discovery companies.<\/p>\n\n\n\n<p>We have developped and validated so far more than 15 disease models, and our flexible and human-sized organization can design and operate tailored experimental protocols to give you appropriate answers.<\/p>\n\n\n\n<p>Our main activities consit in&nbsp;:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Drug Efficacy Studies<\/strong> in several therapeutic areas\u00a0:\n<ul class=\"wp-block-list\">\n<li>Central Nervous Sytem,<\/li>\n\n\n\n<li>Cardiovascular and Metabolic disease,<\/li>\n\n\n\n<li>Respiratory.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Early bioavailibility and CNS-PK<\/strong> on rodents and non-rodents with a high competence in the study of the Blood Brain Barrier passage.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Discover BACK from the 2nd Annual Neuroscience R&#038;D Technologies Conference: Syncrosome, participated last week to the Neuroscience R&#038;D Technologies Conference in London, to present key\u2026<\/p>\n","protected":false},"author":13,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[207],"tags":[],"aire-therapeutique":[229],"class_list":["post-36553","post","type-post","status-publish","format-standard","hentry","category-science-and-innovation","aire-therapeutique-neurologie-cns"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>In vivo Parkinson&#039;s disease models<\/title>\n<meta name=\"description\" content=\"Syncrosome is a preclinical CRO specialized in in vivo preclinical efficacy models in Parkinson area and CNS-PK technics\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.etap-lab.com\/en\/science-and-innovation\/parkinson-in-vivo-preclinical-disease-model\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"In vivo Parkinson&#039;s disease models\" \/>\n<meta property=\"og:description\" content=\"Syncrosome is a preclinical CRO specialized in in vivo preclinical efficacy models in Parkinson area and CNS-PK technics\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.etap-lab.com\/en\/science-and-innovation\/parkinson-in-vivo-preclinical-disease-model\/\" \/>\n<meta property=\"og:site_name\" content=\"ETAP-LAB\" \/>\n<meta property=\"article:published_time\" content=\"2016-10-11T09:47:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-17T15:51:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.etap-lab.com\/wp-content\/uploads\/2020\/12\/IMG_6076-300x225.jpg\" \/>\n<meta name=\"author\" content=\"Ana\u00efs GAVOILLE\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ana\u00efs GAVOILLE\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/science-and-innovation\\\/parkinson-in-vivo-preclinical-disease-model\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/science-and-innovation\\\/parkinson-in-vivo-preclinical-disease-model\\\/\"},\"author\":{\"name\":\"Ana\u00efs GAVOILLE\",\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/#\\\/schema\\\/person\\\/5795847a84eb95e1faecaac7eaf85ba9\"},\"headline\":\"BACK from the 2nd Annual Neuroscience R&#038;D Technologies Conference\",\"datePublished\":\"2016-10-11T09:47:00+00:00\",\"dateModified\":\"2026-04-17T15:51:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/science-and-innovation\\\/parkinson-in-vivo-preclinical-disease-model\\\/\"},\"wordCount\":300,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/science-and-innovation\\\/parkinson-in-vivo-preclinical-disease-model\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.etap-lab.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/IMG_6076-300x225.jpg\",\"articleSection\":[\"Science and innovation\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/science-and-innovation\\\/parkinson-in-vivo-preclinical-disease-model\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/science-and-innovation\\\/parkinson-in-vivo-preclinical-disease-model\\\/\",\"url\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/science-and-innovation\\\/parkinson-in-vivo-preclinical-disease-model\\\/\",\"name\":\"In vivo Parkinson's disease models\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/science-and-innovation\\\/parkinson-in-vivo-preclinical-disease-model\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/science-and-innovation\\\/parkinson-in-vivo-preclinical-disease-model\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.etap-lab.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/IMG_6076-300x225.jpg\",\"datePublished\":\"2016-10-11T09:47:00+00:00\",\"dateModified\":\"2026-04-17T15:51:10+00:00\",\"description\":\"Syncrosome is a preclinical CRO specialized in in vivo preclinical efficacy models in Parkinson area and CNS-PK technics\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/science-and-innovation\\\/parkinson-in-vivo-preclinical-disease-model\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/science-and-innovation\\\/parkinson-in-vivo-preclinical-disease-model\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/science-and-innovation\\\/parkinson-in-vivo-preclinical-disease-model\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.etap-lab.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/IMG_6076-300x225.jpg\",\"contentUrl\":\"https:\\\/\\\/www.etap-lab.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/IMG_6076-300x225.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/science-and-innovation\\\/parkinson-in-vivo-preclinical-disease-model\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Science and innovation\",\"item\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/science-and-innovation\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"BACK from the 2nd Annual Neuroscience R&#038;D Technologies Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/\",\"name\":\"Etap Lab\",\"description\":\"CRO Services\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/#organization\",\"name\":\"Etap Lab\",\"url\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.etap-lab.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/etap-lab-etap-lab-preclinical-cro-right-full-color-rgb-1920px-w-72ppi.png\",\"contentUrl\":\"https:\\\/\\\/www.etap-lab.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/etap-lab-etap-lab-preclinical-cro-right-full-color-rgb-1920px-w-72ppi.png\",\"width\":550,\"height\":550,\"caption\":\"Etap Lab\"},\"image\":{\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/etap-lab\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.etap-lab.com\\\/en\\\/#\\\/schema\\\/person\\\/5795847a84eb95e1faecaac7eaf85ba9\",\"name\":\"Ana\u00efs GAVOILLE\",\"description\":\"Marketing expert at ETAP-LAB.\",\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/in\\\/anais-gavoille-54lorraine\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"In vivo Parkinson's disease models","description":"Syncrosome is a preclinical CRO specialized in in vivo preclinical efficacy models in Parkinson area and CNS-PK technics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.etap-lab.com\/en\/science-and-innovation\/parkinson-in-vivo-preclinical-disease-model\/","og_locale":"en_US","og_type":"article","og_title":"In vivo Parkinson's disease models","og_description":"Syncrosome is a preclinical CRO specialized in in vivo preclinical efficacy models in Parkinson area and CNS-PK technics","og_url":"https:\/\/www.etap-lab.com\/en\/science-and-innovation\/parkinson-in-vivo-preclinical-disease-model\/","og_site_name":"ETAP-LAB","article_published_time":"2016-10-11T09:47:00+00:00","article_modified_time":"2026-04-17T15:51:10+00:00","og_image":[{"url":"https:\/\/www.etap-lab.com\/wp-content\/uploads\/2020\/12\/IMG_6076-300x225.jpg","type":"","width":"","height":""}],"author":"Ana\u00efs GAVOILLE","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ana\u00efs GAVOILLE","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.etap-lab.com\/en\/science-and-innovation\/parkinson-in-vivo-preclinical-disease-model\/#article","isPartOf":{"@id":"https:\/\/www.etap-lab.com\/en\/science-and-innovation\/parkinson-in-vivo-preclinical-disease-model\/"},"author":{"name":"Ana\u00efs GAVOILLE","@id":"https:\/\/www.etap-lab.com\/en\/#\/schema\/person\/5795847a84eb95e1faecaac7eaf85ba9"},"headline":"BACK from the 2nd Annual Neuroscience R&#038;D Technologies Conference","datePublished":"2016-10-11T09:47:00+00:00","dateModified":"2026-04-17T15:51:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.etap-lab.com\/en\/science-and-innovation\/parkinson-in-vivo-preclinical-disease-model\/"},"wordCount":300,"commentCount":0,"publisher":{"@id":"https:\/\/www.etap-lab.com\/en\/#organization"},"image":{"@id":"https:\/\/www.etap-lab.com\/en\/science-and-innovation\/parkinson-in-vivo-preclinical-disease-model\/#primaryimage"},"thumbnailUrl":"https:\/\/www.etap-lab.com\/wp-content\/uploads\/2020\/12\/IMG_6076-300x225.jpg","articleSection":["Science and innovation"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.etap-lab.com\/en\/science-and-innovation\/parkinson-in-vivo-preclinical-disease-model\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.etap-lab.com\/en\/science-and-innovation\/parkinson-in-vivo-preclinical-disease-model\/","url":"https:\/\/www.etap-lab.com\/en\/science-and-innovation\/parkinson-in-vivo-preclinical-disease-model\/","name":"In vivo Parkinson's disease models","isPartOf":{"@id":"https:\/\/www.etap-lab.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.etap-lab.com\/en\/science-and-innovation\/parkinson-in-vivo-preclinical-disease-model\/#primaryimage"},"image":{"@id":"https:\/\/www.etap-lab.com\/en\/science-and-innovation\/parkinson-in-vivo-preclinical-disease-model\/#primaryimage"},"thumbnailUrl":"https:\/\/www.etap-lab.com\/wp-content\/uploads\/2020\/12\/IMG_6076-300x225.jpg","datePublished":"2016-10-11T09:47:00+00:00","dateModified":"2026-04-17T15:51:10+00:00","description":"Syncrosome is a preclinical CRO specialized in in vivo preclinical efficacy models in Parkinson area and CNS-PK technics","breadcrumb":{"@id":"https:\/\/www.etap-lab.com\/en\/science-and-innovation\/parkinson-in-vivo-preclinical-disease-model\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.etap-lab.com\/en\/science-and-innovation\/parkinson-in-vivo-preclinical-disease-model\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.etap-lab.com\/en\/science-and-innovation\/parkinson-in-vivo-preclinical-disease-model\/#primaryimage","url":"https:\/\/www.etap-lab.com\/wp-content\/uploads\/2020\/12\/IMG_6076-300x225.jpg","contentUrl":"https:\/\/www.etap-lab.com\/wp-content\/uploads\/2020\/12\/IMG_6076-300x225.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.etap-lab.com\/en\/science-and-innovation\/parkinson-in-vivo-preclinical-disease-model\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.etap-lab.com\/en\/"},{"@type":"ListItem","position":2,"name":"Science and innovation","item":"https:\/\/www.etap-lab.com\/en\/science-and-innovation\/"},{"@type":"ListItem","position":3,"name":"BACK from the 2nd Annual Neuroscience R&#038;D Technologies Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.etap-lab.com\/en\/#website","url":"https:\/\/www.etap-lab.com\/en\/","name":"Etap Lab","description":"CRO Services","publisher":{"@id":"https:\/\/www.etap-lab.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.etap-lab.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.etap-lab.com\/en\/#organization","name":"Etap Lab","url":"https:\/\/www.etap-lab.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.etap-lab.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.etap-lab.com\/wp-content\/uploads\/2026\/03\/etap-lab-etap-lab-preclinical-cro-right-full-color-rgb-1920px-w-72ppi.png","contentUrl":"https:\/\/www.etap-lab.com\/wp-content\/uploads\/2026\/03\/etap-lab-etap-lab-preclinical-cro-right-full-color-rgb-1920px-w-72ppi.png","width":550,"height":550,"caption":"Etap Lab"},"image":{"@id":"https:\/\/www.etap-lab.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/etap-lab\/"]},{"@type":"Person","@id":"https:\/\/www.etap-lab.com\/en\/#\/schema\/person\/5795847a84eb95e1faecaac7eaf85ba9","name":"Ana\u00efs GAVOILLE","description":"Marketing expert at ETAP-LAB.","sameAs":["https:\/\/www.linkedin.com\/in\/anais-gavoille-54lorraine\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.etap-lab.com\/en\/wp-json\/wp\/v2\/posts\/36553","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.etap-lab.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.etap-lab.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.etap-lab.com\/en\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.etap-lab.com\/en\/wp-json\/wp\/v2\/comments?post=36553"}],"version-history":[{"count":0,"href":"https:\/\/www.etap-lab.com\/en\/wp-json\/wp\/v2\/posts\/36553\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.etap-lab.com\/en\/wp-json\/wp\/v2\/media?parent=36553"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.etap-lab.com\/en\/wp-json\/wp\/v2\/categories?post=36553"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.etap-lab.com\/en\/wp-json\/wp\/v2\/tags?post=36553"},{"taxonomy":"aire-therapeutique","embeddable":true,"href":"https:\/\/www.etap-lab.com\/en\/wp-json\/wp\/v2\/aire-therapeutique?post=36553"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}